Cargando…
A longitudinal case series of IM ketamine for patients with severe and enduring eating disorders and comorbid treatment‐resistant depression
Severe and enduring eating disorders (EDs) have the highest mortality rate of all psychiatric illnesses (Arch Gen Psychiatry, 2011, 68, 724), especially when comorbid with treatment‐resistant depression (TRD) (Psychiatr Res, 2016, 244, 45). We report on four patients with enduring EDs and TRD treate...
Autores principales: | Schwartz, Terry, Trunko, Mary Ellen, Feifel, David, Lopez, Emily, Peterson, Danika, Frank, Guido K. W., Kaye, Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117825/ https://www.ncbi.nlm.nih.gov/pubmed/34026123 http://dx.doi.org/10.1002/ccr3.3869 |
Ejemplares similares
-
A pilot open series of lamotrigine in DBT-treated eating disorders characterized by significant affective dysregulation and poor impulse control
por: Trunko, Mary Ellen, et al.
Publicado: (2017) -
Evaluating the use of lamotrigine to reduce mood lability and impulsive behaviors in adults with chronic and severe eating disorders
por: Reilly, Erin E., et al.
Publicado: (2022) -
A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders
por: Robison, Reid, et al.
Publicado: (2022) -
Safety of Repeated Administration of Parenteral Ketamine for Depression
por: Feifel, David, et al.
Publicado: (2020) -
Prehospital Use of IM Ketamine for Sedation of Violent and Agitated Patients
por: Scheppke, Kenneth A., et al.
Publicado: (2014)